Loading...
Profile Links

June 19, 2024

STENOCARE is expanding into Canada

Stenocare is partnering with a team of industry experts in Canada. Stenocare is one of the first European medical cannabis companies to enter Canada. In support of this growth strategy, the company has partnered with some of Canada’s leading medical cannabis innova…

show more

June 3, 2024

An Update on Stenocare's Strong Product Pipeline

Since 2019, Stenocare has invested in qualifying and developing the new and innovative ASTRUM Oil product. Through a pharmacokinetic study with dogs, it has documented improved bioavailability in the blood, enhanced uniformity of uptake, and reduced t…

show more

May 24, 2024

Product innovation: STENOCARE launch next generation medical cannabis oil product in Australia – six months ahead of schedule. The new Astrum brand is an innovative cannabis oil product featuring a patented oil technology that enhances the bioavailability of its active ingredients. This breakthroug…

show more

May 22, 2024

STENOCARE is sharing early information about the upcoming share issue “TO2 Warrant” transaction in June 2024


STENOCARE A/S (“Stenocare”) announced a year ago (May 2023) that the company would raise capital through three different share issue transactions. The last of these transactions is the upcomi…

show more

May 15, 2024

Stenocare leadership role:

Our CEO, Thomas Skovlund Schnegelsberg, has been invited to serve as a judge for the upcoming 'Business of Cannabis Awards' on June 25, where industry leaders will celebrate individuals and organizations that have made significant contributions to the cannabis industry.

Th…

show more

April 18, 2024

Denmark: The new STENOCARE THC/CBD medical cannabis oil product is now available for sale in Denmark

Starting today the new product is available for sales to patients, and Stenocare is the only supplier of THC/CBD oil products under the Pilot Programme. Out of the many suppliers seeking approval to …

show more

April 16, 2024

Stenocare
Company Update News release 2 months, 3 weeks ago

STENOCARE expands in Australia

Stenocare is a supplier of prescription-based medical cannabis oil products in several markets and has been present in the Australian market since Q4 2022. According to the National Drug Strategy Household Survey and Australian regulator report, the Australian medical …

show more
Stenocare
Company Update News release 2 months, 3 weeks ago

GERMANY: STENOCARE is expanding outside Denmark with more prescription-based products.

Germany is the largest market in Europe with approx. 230.000 patients (out of 87 mill citizens) and projected sales of Euro 1 billion in 2027 – according to industry analysts.

STENOCARE has entered Germany with a …

show more
Stenocare
Company Update News release 2 months, 3 weeks ago

STENOCARE is investing in new innovative medical cannabis products. Future patented protected products.

Since 2019, STENOCARE has been investing and working to develop the next generation of medical cannabis oil products. The company is partnering with both a pharmaceutical product development compa…

show more

Upcoming

Events Upcoming and recent events